Cargando…

Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer

BACKGROUND: There is recent interest in treating locally advanced rectal cancer (LARC) patients with total neoadjuvant therapy (TNT). However, whether TNT is associated with improved overall survival (OS) remains unknown. This study compares outcomes following TNT and following neoadjuvant chemoradi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Shaoyu, Brodin, N. Patrik, English, Keara, Ohri, Nitin, Chuy, Jennifer W., Rajdev, Lakshmi N., Narang, Rahul, Kalnicki, Shalom, Guha, Chandan, Garg, Madhur K., Kabarriti, Rafi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890979/
https://www.ncbi.nlm.nih.gov/pubmed/31832617
http://dx.doi.org/10.1016/j.eclinm.2019.09.009
_version_ 1783475730462539776
author Zhu, Shaoyu
Brodin, N. Patrik
English, Keara
Ohri, Nitin
Chuy, Jennifer W.
Rajdev, Lakshmi N.
Narang, Rahul
Kalnicki, Shalom
Guha, Chandan
Garg, Madhur K.
Kabarriti, Rafi
author_facet Zhu, Shaoyu
Brodin, N. Patrik
English, Keara
Ohri, Nitin
Chuy, Jennifer W.
Rajdev, Lakshmi N.
Narang, Rahul
Kalnicki, Shalom
Guha, Chandan
Garg, Madhur K.
Kabarriti, Rafi
author_sort Zhu, Shaoyu
collection PubMed
description BACKGROUND: There is recent interest in treating locally advanced rectal cancer (LARC) patients with total neoadjuvant therapy (TNT). However, whether TNT is associated with improved overall survival (OS) remains unknown. This study compares outcomes following TNT and following neoadjuvant chemoradiation therapy (nCRT) in patients with LARC, clinically defined cT3/4 or node positive disease, using the National Cancer Database. METHODS: LARC patients diagnosed between 2004–2015 were included. TNT was defined as multi-agent chemotherapy given at least 2 months before RT followed by pre-operative chemoradiation therapy and definitive surgery without adjuvant chemotherapy. nCRT was defined as pre-operative RT and chemotherapy started within 2 weeks from each other followed by definitive surgery with or without adjuvant chemotherapy. Kaplan-Meier curve with logrank test and multivariable Cox proportional hazards regression modelling were used to analyse the primary endpoint of overall survival (OS). Multivariable logistic regression modelling was used for secondary outcomes to determine if TNT is associated with pathological complete response (pCR), defined as ypT0N0, and negative circumferential resection margin (CRM). FINDINGS: Data from 372 TNT patients and 707 nCRT patients were analysed after a 2:1 propensity matching with replacement. Kaplan-Meier curve showed that OS with TNT was comparable to that with nCRT (p = 0•16). The 5-year OS rates for TNT and nCRT were 73•6% vs. 78•5% (p = 0•20). Multivariable Cox proportional hazards regression modelling confirmed no difference in OS between TNT and nCRT (HR = 1•21, p = 0•25). With TNT, 16•9% patients achieved pCR, whereas 13•1% patients achieved pCR with nCRT (p = 0•12). TNT was not found to be significantly associated with pCR (OR = 1•36, p = 0•13) or negative CRM (OR = 1•77, p = 0•19) in multivariable logistic regression modelling. INTERPRETATION: With results from current clinical trials pending, our data suggested that TNT and nCRT resulted in similar survival, while TNT led to higher pCR and CRM negative rate, albeit not statistically significant.
format Online
Article
Text
id pubmed-6890979
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68909792019-12-12 Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer Zhu, Shaoyu Brodin, N. Patrik English, Keara Ohri, Nitin Chuy, Jennifer W. Rajdev, Lakshmi N. Narang, Rahul Kalnicki, Shalom Guha, Chandan Garg, Madhur K. Kabarriti, Rafi EClinicalMedicine Research Paper BACKGROUND: There is recent interest in treating locally advanced rectal cancer (LARC) patients with total neoadjuvant therapy (TNT). However, whether TNT is associated with improved overall survival (OS) remains unknown. This study compares outcomes following TNT and following neoadjuvant chemoradiation therapy (nCRT) in patients with LARC, clinically defined cT3/4 or node positive disease, using the National Cancer Database. METHODS: LARC patients diagnosed between 2004–2015 were included. TNT was defined as multi-agent chemotherapy given at least 2 months before RT followed by pre-operative chemoradiation therapy and definitive surgery without adjuvant chemotherapy. nCRT was defined as pre-operative RT and chemotherapy started within 2 weeks from each other followed by definitive surgery with or without adjuvant chemotherapy. Kaplan-Meier curve with logrank test and multivariable Cox proportional hazards regression modelling were used to analyse the primary endpoint of overall survival (OS). Multivariable logistic regression modelling was used for secondary outcomes to determine if TNT is associated with pathological complete response (pCR), defined as ypT0N0, and negative circumferential resection margin (CRM). FINDINGS: Data from 372 TNT patients and 707 nCRT patients were analysed after a 2:1 propensity matching with replacement. Kaplan-Meier curve showed that OS with TNT was comparable to that with nCRT (p = 0•16). The 5-year OS rates for TNT and nCRT were 73•6% vs. 78•5% (p = 0•20). Multivariable Cox proportional hazards regression modelling confirmed no difference in OS between TNT and nCRT (HR = 1•21, p = 0•25). With TNT, 16•9% patients achieved pCR, whereas 13•1% patients achieved pCR with nCRT (p = 0•12). TNT was not found to be significantly associated with pCR (OR = 1•36, p = 0•13) or negative CRM (OR = 1•77, p = 0•19) in multivariable logistic regression modelling. INTERPRETATION: With results from current clinical trials pending, our data suggested that TNT and nCRT resulted in similar survival, while TNT led to higher pCR and CRM negative rate, albeit not statistically significant. Elsevier 2019-10-22 /pmc/articles/PMC6890979/ /pubmed/31832617 http://dx.doi.org/10.1016/j.eclinm.2019.09.009 Text en © 2019 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Zhu, Shaoyu
Brodin, N. Patrik
English, Keara
Ohri, Nitin
Chuy, Jennifer W.
Rajdev, Lakshmi N.
Narang, Rahul
Kalnicki, Shalom
Guha, Chandan
Garg, Madhur K.
Kabarriti, Rafi
Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
title Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
title_full Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
title_fullStr Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
title_full_unstemmed Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
title_short Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
title_sort comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890979/
https://www.ncbi.nlm.nih.gov/pubmed/31832617
http://dx.doi.org/10.1016/j.eclinm.2019.09.009
work_keys_str_mv AT zhushaoyu comparingoutcomesfollowingtotalneoadjuvanttherapyandfollowingneoadjuvantchemoradiationtherapyinpatientswithlocallyadvancedrectalcancer
AT brodinnpatrik comparingoutcomesfollowingtotalneoadjuvanttherapyandfollowingneoadjuvantchemoradiationtherapyinpatientswithlocallyadvancedrectalcancer
AT englishkeara comparingoutcomesfollowingtotalneoadjuvanttherapyandfollowingneoadjuvantchemoradiationtherapyinpatientswithlocallyadvancedrectalcancer
AT ohrinitin comparingoutcomesfollowingtotalneoadjuvanttherapyandfollowingneoadjuvantchemoradiationtherapyinpatientswithlocallyadvancedrectalcancer
AT chuyjenniferw comparingoutcomesfollowingtotalneoadjuvanttherapyandfollowingneoadjuvantchemoradiationtherapyinpatientswithlocallyadvancedrectalcancer
AT rajdevlakshmin comparingoutcomesfollowingtotalneoadjuvanttherapyandfollowingneoadjuvantchemoradiationtherapyinpatientswithlocallyadvancedrectalcancer
AT narangrahul comparingoutcomesfollowingtotalneoadjuvanttherapyandfollowingneoadjuvantchemoradiationtherapyinpatientswithlocallyadvancedrectalcancer
AT kalnickishalom comparingoutcomesfollowingtotalneoadjuvanttherapyandfollowingneoadjuvantchemoradiationtherapyinpatientswithlocallyadvancedrectalcancer
AT guhachandan comparingoutcomesfollowingtotalneoadjuvanttherapyandfollowingneoadjuvantchemoradiationtherapyinpatientswithlocallyadvancedrectalcancer
AT gargmadhurk comparingoutcomesfollowingtotalneoadjuvanttherapyandfollowingneoadjuvantchemoradiationtherapyinpatientswithlocallyadvancedrectalcancer
AT kabarritirafi comparingoutcomesfollowingtotalneoadjuvanttherapyandfollowingneoadjuvantchemoradiationtherapyinpatientswithlocallyadvancedrectalcancer